Close menu




 

Mario Hose

  • Business models
  • Ressources
  • Energy
  • Innovations

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. The large number of journeys and participation in events have enabled him to build up a personal network.

As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders. Besides precious metals and energy sources, innovations from various industries are of particular interest.

Since the 1990s, extensive experience in the capital market from various perspectives has been gained. The anecdotes from this time are now paired with the expert knowledge from his business studies in the current commentaries in an entertaining way.


Commented by Mario Hose

Commented by Mario Hose on February 13th, 2020 | 15:06 CET

Ballard Power, dynaCERT, NEL ASA - where else is it worth investing?

  • Hydrogen

For investors, rising share prices are a confirmation of a successful investment decision. However, experienced market participants also know that from time to time it makes sense to take chips off the table - in other words, to realize profits. It is both important and difficult to assess the market potential of innovations. If a share has doubled in value, it does not necessarily mean that it will only be half as attractive from now on. In the context of social trends, topics can generate investor demand for a much longer period of time and more intensively.

Read

Commented by Mario Hose on February 13th, 2020 | 12:52 CET

Infineon, Memphasys, Steinhoff - the potential of scalability

  • Success

The charm and lure of optically low share prices can lead to an extraordinary return in the event of success. One of the most exciting and successful turnaround stories of the past decades is Infineon. The company went public in the environment of the new market hype, and at the beginning of the new millennium the shares changed hands at over EUR 83.00. In 2009, nine years later, Infineon was traded at less than EUR 0.50 in the wake of the global economic crisis. Those who showed courage back then were able to make a fortune to this day, depending on the number of shares. There are always opportunities.

Read

Commented by Mario Hose on February 13th, 2020 | 08:57 CET

BIGG Digital Assets, Bitcoin Group, Chainalysis - why invest now?

  • Blockchain

The blockchain hype was around two years ago and a lot has changed since then. A consolidation phase has cleared the market and what has remained are the companies and teams that have been able to convince the market and investors of their products and business models. The interest in the sector is often reinterpreted by market participants into the price development of the most famous crypto-currency. The price of a Bitcoin was quoted in the morning at over USD 10,400.00, the highest level since September 2019, and about two months ago the digital currency changed wallets at less than USD 7,000.00. This volatility enabled a speculative gain of about 50%. But the market offers more.

Read

Commented by Mario Hose on February 11th, 2020 | 14:55 CET

Aphria, Canopy Growth, EXMceuticals - Europe becomes the largest cannabis market

  • Cannabis

The consulting firm Prohibition Partners expects Europe to grow into the world's largest market for legal cannabis products in the next five years. Germany will become by far the largest market for medical cannabis products. According to the experts, Europe will thus overtake the North American market.

Read

Commented by Mario Hose on February 4th, 2020 | 05:50 CET

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

  • Cannabis

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other pharmaceutical products. The market and attitudes towards cannabis are now changing. Doctors, patients, companies and investors see opportunities to profit from this development.

Read

Commented by Mario Hose on January 30th, 2020 | 07:34 CET

After M1 now CR Capital with price jump: When does MPH share react?

  • Clinic

The holding company MPH Health Care AG can be pleased about the positive development of its investments. After the share price of M1 Klinken AG had increased significantly in recent weeks, driven among other things by positive analyst comments and the successful international expansion, the share of CR Capital Real Estate AG yesterday rose by 12.4% to EUR 36.20. The MPH share should also benefit from this development. The value of the M1 participation alone meanwhile exceeds the total market capitalisation of MPH of EUR 178 million. Thus, investors will receive the 50-percent shareholdings in CR Capital and Haemato AG with a combined market value of EUR 100 million free of charge. When does the MPH share react?

Read

Commented by Mario Hose on January 27th, 2020 | 07:33 CET

Burcon, Canopy, dynaCERT - how cannabis, proteins and hydrogen improve the world

  • Sustainability

Innovations continuously change our lives. Entrepreneurs around the globe are trying to make things happen, developing products and technologies that are designed to improve everyday life. Business areas that are scalable are particularly successful. Once a product is ready to go into production and can be sold in countless quantities, it is tantamount to a license to print money. Such topics are particularly exciting when the ingredients grow naturally or already occur in nature and only a technical process is required to create a new end product.

Read

Commented by Mario Hose on January 24th, 2020 | 14:11 CET

Beyond Meat, Burcon NutraScience, Nestle - scalable growth with plant proteins

  • Food

Humanity is always striving for improvement. This has not only been the case since the climate debate, but innovations in all areas of everyday life are constantly changing our lives. The changes will never again be as slow as they are at this moment. Research and development solve problems or create new needs. In the ideal case even both. Nutritious and tasty food with an improved CO2 footprint is on the agenda of food producers like Beyond Meat and Nestle. But developing innovation costs not only money, but also time. The latter usually leads to partnerships or even takeovers.

Read

Commented by Mario Hose on January 23rd, 2020 | 14:26 CET

TESLA - does a short squeeze like once at Volkswagen threaten?

  • Short squeeze

In the language of traders, the covering of short position in a rapidly rising market with a scarce supply is called short squeeze. So-called short sellers have previously borrowed shares from banks or other investors and then sold them because they wanted to bet on falling prices. If the share subsequently falls, the deal works out successfully. However, if the share rises, losses can occur when the position is closed out again so that the borrowed shares can be returned.

Read

Commented by Mario Hose on January 23rd, 2020 | 05:50 CET

Berenberg says "buy": Next recommendation for MPH investment M1 Kliniken AG

  • Clinic

The analysts at Berenberg have begun coverage of M1 Klinken AG and have recommended the share as a buy. With more than 70 doctors and over 200,000 treatments annually, M1 is the market leader for beauty medicine in Germany. Thanks to its strategy "highest quality at the best price", the company has been able to achieve annual growth rates of around 30% since 2014. The investment of MPH Health Care, which is also listed on the stock exchange, should also grow significantly in the future. The driving forces are the increasing market penetration in Germany and the international rollout. The analysts expect EBIT to grow by 30% annually until 2022 and recommend buying the M1 share with a price target of EUR 18. Analysts from Commerzbank, Kempler or GBC also recommend buying.

Read